Journal of Endocrinology and Metabolism, ISSN 1923-2861 print, 1923-287X online, Open Access
Article copyright, the authors; Journal compilation copyright, J Endocrinol Metab and Elmer Press Inc
Journal website http://www.jofem.org

Case Report

Volume 3, Number 4-5, October 2013, pages 119-123


Effects of an Inhibitor of 3β-Hydroxysteroid Dehydrogenase on Glucose, Lipid Metabolism and Adipose Tissue in a Patient With Type 2 Diabetes

Figures

Figure 1.
Figure 1. Changes of urinary cortisol concentration (A), subcutaneous fat area (B) and visceral fat area (C) by using trilostane (240 mg/day and 120 mg/day).
Figure 2.
Figure 2. Changes of serum levels of high-density lipoprotein-cholesterol (HDL-C) (A), low-density lipoprotein-cholesterol (LDL-C) (B), intermediate-density lipoprotein-cholesterol (IDL-C) (C), very low-density lipoprotein-cholesterol (VLDL-C) (D) and chylomicron-cholesterol (CM-C) (E) by using trilostane (240 mg/day and 120 mg/day).
Figure 3.
Figure 3. Changes of serum levels of lipoprotein (a) (A), small dense low-density lipoprotein (LDL) (B), oxidized low-density lipoprotein (LDL) (C) and adiponectin by using trilostane (240 mg/day and 120 mg/day).